125 related articles for article (PubMed ID: 38294129)
1. Protective effect of alpha-lipoic acid and epalrestat on oxaliplatin-induced peripheral neuropathy in zebrafish.
Lee DW; Park HC; Kim DH
Muscle Nerve; 2024 Apr; 69(4):498-503. PubMed ID: 38294129
[TBL] [Abstract][Full Text] [Related]
2. Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Drug Des Devel Ther; 2018; 12():2827-2840. PubMed ID: 30233145
[TBL] [Abstract][Full Text] [Related]
3. The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
Wang X; Lin H; Xu S; Jin Y; Zhang R
Medicine (Baltimore); 2018 Feb; 97(6):e9828. PubMed ID: 29419686
[TBL] [Abstract][Full Text] [Related]
4. Lipoic Acid Combined with Epalrestat versus Lipoic Acid in Treating Diabetic Peripheral Neuropathy:A Meta-analysis.
Wang XT; Lin HX; Xu SA; Lu YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):656-664. PubMed ID: 29125108
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of epalrestat plus α-lipoic acid combination therapy
Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
[TBL] [Abstract][Full Text] [Related]
6. Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.
Lee KA; Lee NY; Park TS; Jin HY
Endocrine; 2018 Jul; 61(1):58-67. PubMed ID: 29736880
[TBL] [Abstract][Full Text] [Related]
7. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
Guo Y; Jones D; Palmer JL; Forman A; Dakhil SR; Velasco MR; Weiss M; Gilman P; Mills GM; Noga SJ; Eng C; Overman MJ; Fisch MJ
Support Care Cancer; 2014 May; 22(5):1223-31. PubMed ID: 24362907
[TBL] [Abstract][Full Text] [Related]
8. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
Jin HY; Lee NY; Ko HA; Lee KA; Park TS
Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
[TBL] [Abstract][Full Text] [Related]
9. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
[TBL] [Abstract][Full Text] [Related]
10. [Examination of questionnaires regarding diabetic peripheral neuropathy in epalrestat-treated patients and their usefulness in the treatment of the patients during the treatment course].
Ito A; Ishii-Nozawa R; Ibuki C; Atarashi H; Kataoka H; Takeuchi K
Yakugaku Zasshi; 2009 Oct; 129(10):1239-47. PubMed ID: 19797880
[TBL] [Abstract][Full Text] [Related]
11. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
12. Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy.
Fujita S; Hirota T; Sakiyama R; Baba M; Ieiri I
J Neurochem; 2019 Feb; 148(3):373-385. PubMed ID: 30295925
[TBL] [Abstract][Full Text] [Related]
13. [Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study].
Liu F; Zhang Y; Yang M; Liu B; Shen YD; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2706-9. PubMed ID: 18167250
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
15. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data.
Maschio M; Zarabla A; Maialetti A; Marchesi F; Giannarelli D; Gumenyuk S; Pisani F; Renzi D; Galiè E; Mengarelli A
Integr Cancer Ther; 2018 Dec; 17(4):1115-1124. PubMed ID: 30295079
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation.
Agnes JP; Santos VWD; das Neves RN; Gonçalves RM; Delgobo M; Girardi CS; Lückemeyer DD; Ferreira MA; Macedo-Júnior SJ; Lopes SC; Spiller F; Gelain DP; Moreira JCF; Prediger RD; Ferreira J; Zanotto-Filho A
J Pain; 2021 Aug; 22(8):996-1013. PubMed ID: 33774154
[TBL] [Abstract][Full Text] [Related]
18. Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.
Cerles O; Gonçalves TC; Chouzenoux S; Benoit E; Schmitt A; Bennett Saidu NE; Kavian N; Chéreau C; Gobeaux C; Weill B; Coriat R; Nicco C; Batteux F
Acta Neuropathol Commun; 2019 Jan; 7(1):9. PubMed ID: 30657060
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of phosphatidylcholine on oxaliplatin-induced neuropathy in rats.
Kim ST; Chung YH; Lee HS; Chung SJ; Lee JH; Sohn UD; Shin YK; Park ES; Kim HC; Bang JS; Jeong JH
Life Sci; 2015 Jun; 130():81-7. PubMed ID: 25817232
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats.
Jaiswal S; Mishra S; Torgal SS; Shengule S
Life Sci; 2018 Aug; 207():364-371. PubMed ID: 29936149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
